SMTI — Sanara Medtech Cashflow Statement
0.000.00%
Last trade - 00:00- $158.04m
- $187.42m
- $103.12m
Annual cashflow statement for Sanara Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.99 | -8.09 | -4.44 | -9.91 | -37.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.76 | 5.49 | 0.7 | 5.67 | 39.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.18 | 0.518 | -3.18 | -0.701 | 1.12 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.81 | -5.55 | -3.25 | -0.024 | 6.79 |
| Capital Expenditures | -0.75 | -0.747 | -0.265 | -0.229 | -4.65 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -4.53 | -2.76 | -9.94 | -6.38 | -10.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.28 | -3.51 | -10.2 | -6.61 | -15 |
| Financing Cash Flow Items | -0.643 | -0.627 | -0.047 | -2.22 | -1.48 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.3 | -0.627 | 9.64 | 17.4 | 8.89 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.2 | -9.69 | -3.81 | 10.7 | 0.701 |